580 filings
Page 12 of 29
S-3
OCX
OncoCyte Corporation
Shelf registration
28 May 21
5:06pm
CORRESP
OCX
OncoCyte Corporation
28 May 21
Correspondence with SEC
12:00am
3
Li Yu
24 May 21
OncoCyte / Li Yu ownership change
7:19pm
DEFA14A
OCX
OncoCyte Corporation
21 May 21
Additional proxy soliciting materials
4:10pm
DEF 14A
OCX
OncoCyte Corporation
Definitive proxy
21 May 21
4:05pm
8-K
OCX
OncoCyte Corporation
21 May 21
Departure of Directors or Certain Officers
8:00am
8-K
OCX
OncoCyte Corporation
17 May 21
Oncocyte Reports First Quarter 2021 Financial Results and Provides Corporate Update
5:19pm
10-Q
2021 Q1
OCX
OncoCyte Corporation
Quarterly report
17 May 21
4:06pm
PRE 14A
OCX
OncoCyte Corporation
Preliminary proxy
10 May 21
8:00am
4
OCX
OncoCyte Corporation
30 Apr 21
OncoCyte / Mitchell S Levine ownership change
7:09pm
10-K/A
2020 FY
OCX
OncoCyte Corporation
Annual report (amended)
30 Apr 21
8:30am
D
OCX
OncoCyte Corporation
29 Apr 21
$17.5M in equity, sold $3.01M, 75 investors
4:44pm
8-K
OCX
OncoCyte Corporation
19 Apr 21
Entry into a Material Definitive Agreement
1:44pm
4
OCX
OncoCyte Corporation
22 Mar 21
OncoCyte / RONALD ASBURY ANDREWS ownership change
5:17pm
10-K
2020 FY
OCX
OncoCyte Corporation
Annual report
19 Mar 21
5:30pm
8-K
OCX
OncoCyte Corporation
16 Mar 21
Oncocyte Provides Corporate Update and Reports Fourth Quarter and Annual 2020 Financial Results
4:36pm
D
OCX
OncoCyte Corporation
8 Mar 21
$5M in equity, sold $5M, 7 investors
4:13pm
CERT
OCX
OncoCyte Corporation
5 Mar 21
Certification of approval for exchange listing
1:43pm
25
OCX
OncoCyte Corporation
5 Mar 21
Voluntary exchange delisting
8:00am
4
OCX
OncoCyte Corporation
1 Mar 21
OncoCyte / Padmavathi Sundar ownership change
4:35pm